DXC on Life Sciences

News, trends and technology insights for the life sciences industry

Leveraging Digital Innovation for Efficiency, Productivity and Insight

The digital and automation age is upon us and life sciences companies have enormous scope for process improvement by tapping into new capabilities. More effective use of resources and improved outcomes are key drivers for life sciences companies. These goals can be achieved through using better analytics to derive greater insights from regulatory data, bringing […]

Where, When and How: Brexit Poses Many Questions over the Future Location of the EMA

As the United Kingdom prepares to leave the European Union, the pharmaceutical industry has been battling with uncertainty, particularly with regard to the impact on regulatory processes and market authorization of drugs. Exactly how Brexit will affect the industry remains uncertain, since the UK’s withdrawal from the EU is unprecedented. UK Prime Minister Theresa May […]

Taking the Complexity Out of Regulatory Governance in an Era of Digital Transformation

The fast pace of technology innovation and digital transformation has added another layer of complexity for life sciences companies trying to manage their regulatory governance and compliance. However, at the same time, business leaders need to embrace the digital transformation to create efficiency, drive competitive advantage, reduce costs and deliver business value beyond compliance. How […]

How IDMP May Be the Catalyst to Better Data and Resource Management via the Cloud

cloud DXC Blogs

Life sciences companies are assessing how best to respond to one of the biggest regulatory challenges they have faced in years: Identification of Medicinal Products (IDMP). The problem is that IDMP is a moving target, much remains unknown, and implementation of the standard will be done in iterations. From a systems and process point of […]

How Regulatory Transformation Drives Transparency and Data Access to the Whole Business

There’s a growing realization across life sciences companies that the regulatory function — how it is managed from an infrastructure point of view, how it is governed, and how the data within it is managed and tracked — needs to be consolidated. Increasingly, companies are looking to consolidate their distributed regulatory processes into a centralized, […]

DXC’s Commitment to Life Sciences Publishing Needs Is Constant: Loyalty Is Our Calling Card

What began as a company called ISI and grew under CSC remains strong under the DXC Technology banner. We at DXC Technology understand that a big change such as the recent merger between CSC and Hewlett Packard Enterprise (HPE) Services that created our company can lead to some uncertainty about how much might be changing […]

Mobile Document Access, Review and Approval Combine to Remove the Regulatory Bottleneck

The work environment for regulatory decision makers has changed dramatically in recent years, requiring them to respond rapidly to submission documents and remove any potential roadblocks to bringing products to market. In this environment, regulatory staff must be able to, in a secure way, access documents remotely from mobile devices quickly and easily. Typically, in […]

Preparing ADaM: Why Data Traceability Is Crucial to the Review Process

When companies submit their clinical data to the regulatory authorities, reviewers not only want the raw data properly mapped and organized — as defined by the submission standard Study Data Tabulation Model (SDTM) — but they also want to be able to trace the raw data to where it originated. This is where the standard […]

How to Get a Good Night’s Sleep: Traceability, Accountability and Due Process in Labeling

Transparency and visibility — most would agree that both are essential for accurate insight of any enterprise-wide process.  Labeling and artwork management is no different.  Often it’s the lack of tools and not the lack of intent that’s the problem. In my last blog, I spoke about the problems caused by poor oversight and the […]

Preparing for the “Soft” Side of Cloud Transitions

We tend to give a lot of consideration to the technology and infrastructure aspects of moving to the cloud, but we often overlook the human element. As life sciences companies begin the journey of transitioning from legacy systems and infrastructure to a fully managed cloud service, they need to consider how best — and how […]